Abstract
The present invention provides compounds and compositions containing reduced nicotinamide riboside for use in methods of promoting protective immunity and/or for preventing and/or treating bacterial or viral infections and/or for limiting immune mediated pathology following infection in an individual comprising delivering to the individual in need an effective unit dose form of reduced nicotinamide.
| Original language | English |
|---|---|
| Patent number | US2023133114 |
| IPC | A61P 31/ 04 A I |
| Priority date | 9/03/21 |
| Publication status | Published - 4 May 2023 |